Corient Private Wealth’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$629K Buy
30,644
+3,432
+13% +$78.6K ﹤0.01% 2073
2026
Q1
$596K Sell
27,212
-4,468
-14% -$77.8K ﹤0.01% 1942
2025
Q4
$374K Buy
31,680
+12,328
+64% +$158K ﹤0.01% 2029
2025
Q3
$307K Sell
19,352
-3,338
-15% -$48.4K ﹤0.01% 2099
2025
Q2
$260K Buy
22,690
+3,357
+17% +$37.8K ﹤0.01% 2078
2025
Q1
$262K Buy
19,333
+5,905
+44% +$98.1K ﹤0.01% 1924
2024
Q4
$227K Buy
13,428
+604
+5% +$11.8K ﹤0.01% 2048
2024
Q3
$261K Buy
12,824
+792
+7% +$16.2K ﹤0.01% 2078
2024
Q2
$272K Sell
12,032
-3,342
-22% -$87.5K ﹤0.01% 1969
2024
Q1
$404K Sell
15,374
-4,630
-23% -$132K ﹤0.01% 1739
2023
Q4
$631K Buy
20,004
+4,866
+32% +$132K ﹤0.01% 1487
2023
Q3
$425K Buy
15,138
+236
+2% +$8.1K ﹤0.01% 1575
2023
Q2
$550K Sell
14,902
-9,974
-40% -$304K ﹤0.01% 1408
2023
Q1
$745K Buy
24,876
+9,340
+60% +$308K ﹤0.01% 1209
2022
Q4
$476K Buy
+15,536
New +$466K ﹤0.01% 1157

Other funds holding CC

Corient Private Wealth's CC Position: Q2 2026 in Review

Corient Private Wealth increased its Chemours (CC) stake by 13% in Q2 2026, buying an estimated $78.6K and bringing the position to 30,644 shares worth $629K. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

Corient Private Wealth first reported a position in CC in Q4 2022 and has held it in 15 quarters since. The position peaked at $745K in Q1 2023. 472 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Corient Private Wealth held 30,644 shares of Chemours worth $629K as of Q2 2026.
  • Corient Private Wealth bought 3,432 Chemours shares in Q2 2026, an estimated $78.6K.
  • Chemours made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2073 holding.
  • Corient Private Wealth first reported a position in Chemours in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Chemours position peaked at $745K in Q1 2023.
  • 472 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.